comparing risk among disparate categories, and its recommendations, with input from FDA, will help to identify a framework for making advances in FDA management processes and decisions.


Attachments:

A Statement of Task

B Committee Membership

C Bibliography

D Acknowledgment of Reviewers



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement